Ad. De Fraissinette et al., Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles, CELL BIOL T, 15(2), 1999, pp. 121-135
An in vitro human reconstructed epidermis model (SkinEthic) used for screen
ing acute and chronic skin irritation potential was validated against in vi
vo data from skin tolerability studies. The irritation potential of sodium
lauryl sulfate (SLS), calcipotriol and trans-retinoic acid was investigated
. The in vitro epidermis-like model consists of cultures of keratinocytes f
rom human foreskin on a polycarbonate filter. The modulation of cell viabil
ity, the release and gene expression of proinflammatory cytokines, interleu
kins 1 alpha and 8, and morphological changes were evaluated during 3 days
as endpoints representative for an inflammatory reaction. The cumulative ir
ritation potential of the topical products was evaluated in a human clinica
l study by visual scoring and biophysical measurement of inflammatory skin
reaction after repeated 24 h applications over 3 weeks under Finn chamber p
atches. All topical products that were nonirritating in the human study wer
e noncytotoxic and did not induce cytokine expression in the in vitro acute
model (day 1 exposure). All irritating controls exhibited specific cell vi
ability and cytokine patterns, which were predictive of the in vivo human d
ata. The ranking of mild to moderate skin irritation potential was based on
the lack of cytotoxicity and the presence of cytokine patterns including g
ene expression specific for each irritant, using the chronic in vitro model
(up to 3 days exposure).
The human reconstructed epidermis model SkinEthic was shown to be a reliabl
e preclinical tool predicting the irritation potential of topical products.
Moreover, it is a useful model in a two-step tiered strategy for screening
acute and chronic irritation potential for the selection of vehicles for n
ew topical drugs.